Trophic Nutrition in Patients Submitted to High Flow Oxygen Therapy and / or Non Invasive Mechanical Ventilation

NCT03728452 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 149

Last updated 2024-05-24

No results posted yet for this study

Summary

The decision about the initiation of enteral nutrition therapy in critically ill patients with oxygen therapy needs with HFC and / or NIMV is a matter of debate at present. Despite the benefits associated with this practice in critically ill patients, the scarcity of clinical studies in patients with sufficient methodological quality, as well as the absence of specific recommendations on enteral nutrition therapy in this type of patient, generates controversy in the professionals involved in critical patient care.

Conditions

  • Noninvasive Ventilation
  • Trophic Nutrition

Interventions

PROCEDURE

Trophic Nutrition

According to previously published studies of Trophic Nutritions in critically ill patients, an energy goal of 20-30% estimated caloric needs of 20-30 kcal / kg and a protein intake of 1.2 to 2.0 g / kg / day of proteins will be established. at most 72 hours after the start of nutritional therapy. The rhythm of initiation and increase of enteral contributions will be at the discretion of each participating ICU. Prokinetic or parenteral nutrition (PN) complementary will not be used routinely, leaving its indication at the discretion of the responsible physician. A hyperproteic nutritional formula (10 g / 100 ml) will be used, with a caloric intake of 1.2 kcal / ml and a non-protein kcal / nitrogen ratio of 52: 1. TN will be administered over 23 hours each day by continuous infusion pump. The head of the patient's bed will rise above 30° as much as possible to reduce the risk of aspiration. The Gastric Residue Volume (GRV) will be measured every 24 hours.

Sponsors & Collaborators

  • Hospital Universitario de Gran Canaria Doctor Negrín

    collaborator UNKNOWN
  • Hospital Universitario Fundación Jiménez Díaz

    collaborator OTHER
  • Hospital Barbastro

    collaborator UNKNOWN
  • Hospital del Rio Hortega

    collaborator OTHER
  • Hospital Universitario Infanta Cristina

    collaborator OTHER
  • Hospital Universitario Ramon y Cajal

    collaborator OTHER
  • University Hospital of Girona Dr. Josep Trueta

    collaborator NETWORK
  • Hospital Universitario Infanta Leonor

    collaborator OTHER
  • Hospital Regional Universitario Carlos Haya

    collaborator OTHER
  • Hospital de Cruces

    collaborator OTHER
  • Hospital Universitario 12 de Octubre

    collaborator OTHER
  • Hospital Universitario Virgen de la Arrixaca

    collaborator OTHER
  • Hospital Virgen de la Concha

    collaborator UNKNOWN
  • Hospital Universitario de Torrevieja

    collaborator UNKNOWN
  • Complejo Hospitalario Universitario de Santiago

    collaborator OTHER
  • Hospital Universitario Puerto Real

    collaborator OTHER
  • Hospital Miguel Servet

    collaborator OTHER
  • Hospital Universitario Severo Ochoa

    collaborator UNKNOWN
  • Hospital Universitario La Fe

    collaborator OTHER
  • Hospital San Carlos, Madrid

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2023-08-01
Completion
2024-02-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03728452 on ClinicalTrials.gov